Pneumococcal vaccine - Antex Biologics
Latest Information Update: 25 Sep 2021
At a glance
- Originator Antex Biologics
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pneumococcal infections
Most Recent Events
- 23 Mar 2007 Discontinued - Preclinical for Pneumococcal infections in USA (unspecified route)
- 02 Jun 1998 Preclinical development for Pneumococcal infections in USA (Unknown route)